SAMD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.675200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.523180E-01
Normal-vs-Stage2
5.817200E-01
Normal-vs-Stage3
1.354450E-01
Normal-vs-Stage4
9.501400E-01
Stage1-vs-Stage2
5.277000E-01
Stage1-vs-Stage3
2.348000E-01
Stage1-vs-Stage4
1.667000E-01
Stage2-vs-Stage3
8.345900E-02
Stage2-vs-Stage4
5.665600E-01
Stage3-vs-Stage4
1.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.049000E-01
Normal-vs-AfricanAmerican
1.704960E-01
Normal-vs-Asian
5.971400E-01
Caucasian-vs-AfricanAmerican
3.790600E-01
Caucasian-vs-Asian
9.506000E-01
AfricanAmerican-vs-Asian
4.463000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.666000E-01
Normal-vs-Female
4.508000E-01
Male-vs-Female
1.594590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.566200E-01
Normal-vs-Age(41-60Yrs)
7.178200E-01
Normal-vs-Age(61-80Yrs)
5.072200E-01
Normal-vs-Age(81-100Yrs)
5.560000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.849200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.451400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.170400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.637570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.977000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.905200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.007800E-01
Normal-vs-Daily Drinker
7.027200E-01
Normal-vs-Weekly Drinker
5.441400E-01
Normal-vs-Occasional Drinker
7.439800E-01
Normal-vs-Social Drinker
4.073200E-01
Non Drinker-vs-Daily Drinker
7.706000E-01
Non Drinker-vs-Weekly Drinker
9.465800E-01
Non Drinker-vs-Occasional Drinker
1.001160E-01
Non Drinker-vs-Social Drinker
7.207400E-01
Daily Drinker-vs-Weekly Drinker
7.524200E-01
Daily Drinker-vs-Occasional Drinker
1.913000E-01
Daily Drinker-vs-Social Drinker
5.437800E-01
Weekly Drinker-vs-Occasional Drinker
1.679830E-01
Weekly Drinker-vs-Social Drinker
7.854000E-01
Occasional Drinker-vs-Social Drinker
8.782200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.588600E-01
Normal-vs-Grade 2
9.948800E-01
Normal-vs-Grade 3
9.578000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.832800E-01
Grade 1-vs-Grade 3
2.248000E-01
Grade 1-vs-Grade 4
9.588600E-01
Grade 2-vs-Grade 3
4.078600E-01
Grade 2-vs-Grade 4
9.948800E-01
Grade 3-vs-Grade 4
9.578000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.469800E-01
Normal-vs-NonDiabetic
6.785200E-01
Diabetic-vs-NonDiabetic
6.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.658600E-01
Normal-vs-NoPancreatitis
6.342200E-01
Pancreatitis-vs-NoPancreatitis
1.174780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.171400E-01
Normal-vs-N1
5.967600E-01
N0-vs-N1
9.705400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.965200E-01
Normal-vs-TP53-NonMutant
5.463200E-01
TP53-Mutant-vs-TP53-NonMutant
1.260810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
